Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer.

Jpn J Clin Oncol · 2022 · PMC9538995 · PMID 36047845

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding this clinical question, a retrospective study showed a trend toward a better PFS with a higher CPS cut-off (CPS 5: HR, 1.33: CPS 10: HR, 0.85; CPS 20: HR, 0.70).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.